Sign Up to like & get
recommendations!
1
Published in 2022 at "JAMA oncology"
DOI: 10.1001/jamaoncol.2022.2398
Abstract: Importance With the advent of potent BCR::ABL1 tyrosine kinase inhibitors (TKIs), Philadelphia chromosome-positive (Ph-positive) acute lymphoblastic leukemia (ALL) is now a relatively favorable-risk acute leukemia. In this review, we discuss the current evidence for frontline…
read more here.
Keywords:
acute;
allogeneic sct;
free regimens;
chemotherapy free ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Archives of Virology"
DOI: 10.1007/s00705-017-3684-7
Abstract: Mixed cryoglobulinemia (MC) is the most common extrahepatic manifestation of chronic hepatitis C (CHC), with the presence of symptoms in 10–15% of cases. There have been encouraging data regarding immunological and clinical responses in patients…
read more here.
Keywords:
free regimens;
role ribavirin;
response;
treatment ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of Gastroenterology and Hepatology"
DOI: 10.1111/jgh.13747
Abstract: Peginterferon/ribavirin has been the standard‐of‐care for chronic hepatitis C virus (HCV) infections: 48 weeks for genotype 1 or 4 (HCV‐1/4) and 24 weeks for HCV‐2/3. Response‐guided therapy recommended shorter 24‐ and 16‐week regimens for HCV‐1…
read more here.
Keywords:
free regimens;
interferon free;
interferon containing;
response ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Liver International"
DOI: 10.1111/liv.13650
Abstract: Interferon (IFN)‐based regimens cause significant impairment of health‐related quality of life (HRQL). Hepatitis C virus (HCV) cure with IFN‐free regimens improves HRQL. The effect of these regimens on HRQL in East Asian HCV patients is…
read more here.
Keywords:
free regimens;
interferon;
health related;
related quality ... See more keywords